S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48

Sientra Stock Forecast, Price & News

-0.04 (-1.42%)
(As of 01/19/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
637,865 shs
Average Volume
530,025 shs
Market Capitalization
$161.58 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive SIEN News and Ratings via Email

Sign-up to receive the latest news and ratings for Sientra and its competitors with MarketBeat's FREE daily newsletter.

Sientra logo

About Sientra

Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. It operates through two reportable segments: Breast Products and miraDry. The Breast Products segment focuses on sales of its breast implants, tissue expanders and scar management products under the brands Sientra, AlloX2, Dermaspan, Softspan and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System, consisting of a console and a handheld device which uses consumable single-use bioTips. The company was founded by Hani M. Zeini on August 29, 2003 and is headquartered in Santa Barbara, CA.


See More Headlines

Industry, Sector and Symbol

Surgical appliances & supplies
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$71.24 million
Book Value
($0.01) per share


Net Income
$-89.95 million
Net Margins
Pretax Margin




Free Float
Market Cap
$161.58 million

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

2.18 out of 5 stars

Medical Sector

412th out of 1,415 stocks

Surgical Appliances & Supplies Industry

9th out of 28 stocks

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

Sientra (NASDAQ:SIEN) Frequently Asked Questions

Is Sientra a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Sientra stock.
View analyst ratings for Sientra
or view top-rated stocks.

How has Sientra's stock price been impacted by Coronavirus?

Sientra's stock was trading at $2.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SIEN shares have increased by 13.9% and is now trading at $2.78.
View which stocks have been most impacted by COVID-19

When is Sientra's next earnings date?

Sientra is scheduled to release its next quarterly earnings announcement on Thursday, March 10th 2022.
View our earnings forecast for Sientra

How were Sientra's earnings last quarter?

Sientra, Inc. (NASDAQ:SIEN) announced its quarterly earnings results on Wednesday, November, 10th. The medical instruments supplier reported ($0.08) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.26) by $0.18. The medical instruments supplier had revenue of $19.62 million for the quarter, compared to analysts' expectations of $18.10 million. During the same period in the previous year, the company posted ($0.33) EPS.
View Sientra's earnings history

What guidance has Sientra issued on next quarter's earnings?

Sientra updated its FY 2021 earnings guidance on Wednesday, December, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $76 million-$78 million, compared to the consensus revenue estimate of $80.95 million.

What price target have analysts set for SIEN?

3 brokers have issued 1 year target prices for Sientra's shares. Their forecasts range from $8.24 to $11.00. On average, they anticipate Sientra's stock price to reach $9.75 in the next twelve months. This suggests a possible upside of 250.6% from the stock's current price.
View analysts' price targets for Sientra
or view top-rated stocks among Wall Street analysts.

Who are Sientra's key executives?

Sientra's management team includes the following people:
  • Ronald Menezes, President, Chief Executive Officer & Director
  • Jeffrey S. Jones, Vice President-Operations
  • Andrew C. Schmidt, Chief Financial Officer, Treasurer & Senior VP
  • Kim Porter, Vice President-Information Technology
  • Denise Dajles, Vice President-Research & Development

What other stocks do shareholders of Sientra own?

What is Sientra's stock symbol?

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Who are Sientra's major shareholders?

Sientra's stock is owned by many different retail and institutional investors. Top institutional shareholders include Future Financial Wealth Managment LLC (0.01%). Company insiders that own Sientra stock include Andrew C Schmidt, Andrew C Schmidt, Hove Caroline F Van, Jeffrey M Nugent, Oliver Christian Bennett, Paul Sean Little, Ronald Menezes and Valerie J Miller.
View institutional ownership trends for Sientra

Which major investors are buying Sientra stock?

SIEN stock was acquired by a variety of institutional investors in the last quarter, including Future Financial Wealth Managment LLC. Company insiders that have bought Sientra stock in the last two years include Andrew C Schmidt, and Ronald Menezes.
View insider buying and selling activity for Sientra
or or view top insider-buying stocks.

How do I buy shares of Sientra?

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sientra's stock price today?

One share of SIEN stock can currently be purchased for approximately $2.78.

How much money does Sientra make?

Sientra has a market capitalization of $161.58 million and generates $71.24 million in revenue each year. The medical instruments supplier earns $-89.95 million in net income (profit) each year or ($1.86) on an earnings per share basis.

How many employees does Sientra have?

Sientra employs 255 workers across the globe.

What is Sientra's official website?

The official website for Sientra is www.sientra.com.

Where are Sientra's headquarters?

How can I contact Sientra?

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at (805) 562-3500, via email at [email protected], or via fax at 805-562-8401.

This page was last updated on 1/20/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.